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adiposity of the individual, we hypothesized that this effect could be due
to the modulation of inﬁltrating T cells by the tissue-resident adipocytes.
Therefore, we investigated whether adipocytes from IFP can modulate
CD4+ T cell cytokine production.
Methods: CD4+ T cells were puriﬁed from peripheral blood mononuclear
cells isolated from buffycoats obtained from healthy volunteers. The
purity of the CD4+ T cells isolated using magnetic beads coated with
anti-human CD4 was above 95%. Plate-bound anti-CD3 and soluble anti-
CD28 antibodies were used to activate T cells. Adipocytes were isolated
from IFP of OA patients by collagenase digestion and were either cultured
with puriﬁed CD4+ T cells or were cultured in vitro for 24 hours in
DMEM/F12 medium supplemented with 0.5% bovine serum albumin
to generate adipocyte-conditioned medium (ACM). Cytokine production
was measured by intracellular cytokine staining (ICS), ELISA or cytokine
multiplex. Separation of the protein and lipid fractions was performed
using the Bligh and Dyer method, followed by precipitation of the protein
fraction and reconstitution in culture medium.
Results: CD4+ T cells produced increase levels of IFNg when activated
in the presence of adipocytes. This effect is mediated by soluble
mediators, as shown in transwell and ACM transfer experiments.
Moreover, separation of the protein and lipid fractions from the ACM
medium showed that soluble factors present in the protein fraction can
mediate this effect. Measurement of ten different cytokines known to
be secreted by T cells upon activation revealed that, besides IFNg, also
TNFa, IL-17 and IL-5 are modulated by IFP-derived ACM.
Conclusions: Soluble mediators secreted by IFP of OA patients can
modulate cytokine production of CD4+ T cells. Although the precise
mechanism involved in this modulation is still unknown, protein/lipid
fractionation studies indicated that molecules present in the protein
fraction can mediate this effect.
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Purpose: Tenascin-C (TNC) is a modular, multifunctional extracellular
matrix glycoprotein associated with the development of articular
cartilage that decreases during maturation of chondrocytes, and almost
disappears in adult cartilage. It is highly reexpressed in the cartilage and
synovium of diseased joints [1], and stimulates the production of pro-
inﬂammatory cytokines in human macrophages and synovial ﬁbroblasts
through activation of Toll-like receptor-4 (TLR4) [2]. We have shown
elevated levels of TNC in joint ﬂuid in animal models of joint disease [3],
and shown the capacity of TNC to induce inﬂammatory mediators and
matrix degradation in vitro in human joint cartilage [4]. The objective
of this study was to determine the release of TNC into synovial ﬂuid of
patients in joint disease and after joint injury, and to correlate levels of
TNC with markers of cartilage matrix degradation and inﬂammation in
the same ﬂuids.
Methods: Human knee synovial ﬂuids (n = 160) were obtained without
lavage from a cross-sectional convenience cohort. Diagnosis was
by arthroscopy, radiography, assessment of joint ﬂuid and clinical
examination. Diagnostic groups were knee healthy reference (REF
n=8), anterior cruciate ligament rupture, with or without concomitant
meniscus lesions (ACL n=56), isolated meniscus injury (MI n =69), acute
inﬂammatory arthritis (AIA n=16) and osteoarthritis (OA n=11). TNC
was measured using TNC Large ELISA (IBL®), with anti-TN-C 19C4MS mab
against the FNIII-C domain for capture, and HRP conjugated anti-TN-C
4F10TT mouse mab against the EGF domain for detection. ARG-aggrecan,
MMP1 and MMP3 ELISAs were performed as described [5,6].
Results: TNC in synovial ﬂuids varied widely between 44 and 2430ng/ml
(Table). Signiﬁcantly higher levels of TNC compared to REF subjects were
observed in all disease groups: 7, 5, 10, and 4-fold higher in ACL, MI, AIA,
and OA, respectively. TNC levels of ACL and MI patients decreased over
time following joint injury. Synovial ﬂuid levels of TNC were signiﬁcantly
correlated with aggrecanase-dependent ARG-aggrecan fragment release
(r = 0.46) and MMP1 (r = 0.51) and MMP3 protein (r = 0.46).
Conclusions: We show strongly elevated levels of TNC in human knee
joints immediately after injury or onset of disease, associated with
markers of inﬂammation and matrix degradation. Due to the complex
function of TNC we can only speculate on the consequences of the
increased TNC release into joint ﬂuid on cartilage matrix function and
disease development. TNC has a role in the assembly of the chondrocyte
matrix and as a soluble mediator of chondrocytes; deﬁciency of TNC
delays articular cartilage repair in mice [7]. The induction by TNC of TLR4,
inﬂammatory pathways, and matrix degradation in articular cartilage is
consistent with the correlation observed in the current study between
TNC levels and ARG-aggrecan fragments, MMP1, and MMP3 in human
synovial ﬂuids. TNC may serve as a marker of joint tissue injury.
ACL MI
Study Group 0–12w 12–52w >52w 0–12w 12–52w >52w AIA OA REF
Mean
sampling
time w
(range)
1 (0–6) 25 (13–48) 279
(57–1115)
3 (0–12) 24 (13–40) 418
(52–1926)
32 (0–510) 189
(0–481)
-
N 26 8 22 27 22 20 16 11 8
Mean age
(range)
25 (14–50) 31 (17–50) 31 (14–53) 34
(18–59)
35 (16–55) 45
(28–70)
68 (30–91) 67
(39–86)
28
(17–42)
Mean
OA grade
(range)
1 (1–3) 2 (1–3) 3 (1–6) 2 (0–5) 2 (0–3) 3 (1–8) 3 (0–9) 8 (3–9) 1 (0–1)
% male 62 63 68 93 86 70 63 45 75
Mean TCN
(ng/ml)
(range)
631
(196–1888)
533
(215–1032)
339
(101–1405)
405
(96–903)
327
(47–1062)
284
(12–1170)
939
(196–2430)
354
(107–817)
91
(44–218)
TNC 95% CI 459, 803 327, 739 212, 466 323, 487 207, 447 165, 402 587, 1290 236, 472 50, 132
Mean fold
/REF
6.9 5.9 3.7 4.5 3.6 3.1 10.3 3.9 -
p-value 0.0009 0.0005 0.0156 0.0001 0.0152 0.0298 0.0016 0.0011 -
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“ALARMINS” S100A8 AND A9 ARE EXPRESSED IN THE SYNOVIUM
OF EARLY OA PATIENTS AND ARE INVOLVED IN DRIVING SYNOVIAL
ACTIVATION AND JOINT DESTRUCTION DURING EXPERIMENTAL
OSTEOARTHRITIS
P. van Lent. Radboud Univ. Nijmegen Med. Ctr., Nijmegen, Netherlands
Purpose: “alarmins” S100 A8 and A9 are prominent proteins released
by activated phagocytes Evidence is accumulating that synovial tissue
activation contributes to OA cartilage pathology The aim was to evaluate
the presence of S100A8/S100A9 in synovia of patients with early OA
and to explore active involvement of S100A8/A9 in cartilage destruction
in experimental osteoarthritis models that differ in degree of synovial
activation.
Methods: Arthroscopic biopsies were taken from 30 early OA patients.
mRNA levels (RT-PCR) and immunolocalisation was determined and
related to joint destruction (Kellgren Lawrence score). Experimental OA
was either induced by transsection of the medial anterior meniscotibial
ligament which leads to destabilisation of the medial meniscus (DMM)
or by injection of collagenase into murine knee joints, which causes
overall ligament damage and broad instability. Collagenase-induced-
osteoarthritis involves chronic synovial activation in contrast to DMM.
Synovial expression of S100A8 and S100A9 was measured using
immunolocalisation. Both models were induced in S100A9−/− deﬁcient
mice (myeloid cells also lack S100A8 at the protein level). Primary
chondrocytes were stimulated with S100A8 and A9 and MMP levels
were measured using RT-PCR.
Results: mRNA and protein levels of S100A8 and A9 were signiﬁcantly
higher in synovial biopsies of early OA patients when compared to control
joints. S100 was predominantly found in synovial macrophages. Of great
interest, high levels correlated to increased joint destruction (KL score).
The function of S100A8 and S100A9 was further studied in experimental
OA models. Kinetic studies show that in surgically induced DMM model,
S100A8 and A9 was marginally expressed within the synovium, only
evident at day 7 after induction and consistent with limited synovial
thickening. The degree of OA cartilage pathology was similar in S100A9−/−
and WT mice at day 42 after induction of DMM.
In contrast, during the course of collagenase-induced osteoarthritis,
S100A8 and S100A9 was strongly upregulated in synovium at day 7
and remained high at days 14, 28 and 42. Expression of these proteins
